Benefit from Renal Cancer Drug Appears Small – MedPage Today
Benefit from Renal Cancer Drug Appears SmallMedPage Today… for advanced renal cell carcinoma — vascular endothelial growth factor (VEGF) receptor inhibitors sorafenib, sunitinib and pazopanib, and VEGF antibody bevacizumab; and mammalian target of r…